Artificial neural network

Aspira Women’s Health Announces Publication of Two OvaWatch Peer-Reviewed Manuscripts

Retrieved on: 
星期二, 五月 7, 2024
Ovarian cancer, Risk, Woman, Gynecologic Oncology (journal), Patient, Gynaecology, Manuscript, Artificial neural network, Risk assessment, Birth control

AUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the publication of two peer-reviewed manuscripts.

Key Points: 
  • AUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the publication of two peer-reviewed manuscripts.
  • The findings of this study demonstrate that use of OvaWatch® to stratify risk in patients with an adnexal mass might help to reduce surgical backlogs and unnecessary surgical referrals.
  • “Today, we mark the publication of additional clinical data to support the use of OvaWatch for the assessment of ovarian cancer risk for women with an adnexal mass,” said Nicole Sandford, Chief Executive Officer of Aspira.
  • Clinicians have long sought a better tool to develop an appropriate care plan for these women, and OvaWatch provides it.”
    “The publication of these manuscripts, along with last week’s announcement to make OvaWatch available for testing over time, is the latest example of Aspira keeping its promises to our stakeholders.

Nano Dimension Announces Another Deep Learning AI Patent Granted to its DeepCube Technology

Retrieved on: 
星期二, 三月 19, 2024
Intel, Artificial neural network, Patent, Artificial intelligence, AI, Software, Confidentiality, AMD, 3D printing, Data

Waltham, Mass., March 19, 2024 (GLOBE NEWSWIRE) --  Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printing solutions, today announced that a patent was granted for technology developed by its industrial artificial intelligence (“AI”) group, DeepCube, that enables better training and optimization of decentralized deep learning-based AI models.

Key Points: 
  • The new patent addresses this challenge by ultimately training and improving the AI models on customers’ premises, without Nano Dimension having direct access to the new data or model.
  • This patent is another key component in Nano Dimension’s efforts to transform DeepCube from a solely in-house AI group to a leading industrial AI solution provider.
  • Nano Dimension’s DeepCube alone has 50 patent applications filed, of which 27 have already been granted.
  • Yoav Stern, Chief Executive Officer and Member of the Board of Directors of Nano Dimension, stated: “Nano Dimension’s leadership in AI continues to make progress.

indie Semiconductor Announces Strategic Investment in AI Processor Leader Expedera

Retrieved on: 
星期三, 三月 20, 2024
Software, Mobile, Wireless, Networks, Internet, Data Management, Apps, Applications, Technology, Artificial Intelligence, Semiconductor, Other Manufacturing, Other Technology, Manufacturing, Automation, Artificial neural network, NN, Partnership, BSD, Perception, Level 2, ADAS, Artificial intelligence, AI, AI accelerator, LKA, AEB, Advanced driver-assistance system, IP, DMS, NCAP, NPU, Multimedia, Silicon, Video game

indie Semiconductor, Inc. (Nasdaq: INDI), an Autotech solutions innovator, today announced a strategic investment in Expedera Inc, a leading provider of scalable Neural Processing Unit (NPU) semiconductor intellectual property (IP).

Key Points: 
  • indie Semiconductor, Inc. (Nasdaq: INDI), an Autotech solutions innovator, today announced a strategic investment in Expedera Inc, a leading provider of scalable Neural Processing Unit (NPU) semiconductor intellectual property (IP).
  • The partnership will deliver customized artificial intelligence (AI) enabled processing capabilities for sensing solutions targeting Advanced Driver Assistance Systems (ADAS) and includes a commercial agreement to integrate customized Expedera OriginTM NPU processing solutions into future indie products.
  • View the full release here: https://www.businesswire.com/news/home/20240320336775/en/
    indie Announces Strategic Investment in AI Processor Leader Expedera (Graphic: Business Wire)
    According to S&P Mobility, by 2029 over 50 percent of vehicles will incorporate Level 2 and above driver automation capabilities, representing a $28 billion ADAS semiconductor opportunity.
  • “Our mission has always been to deliver best-in-market NPU solutions alongside premier partners, which is why we are so thrilled to welcome this new strategic investment and commercial agreement with indie,” said Da Chuang, co-founder and CEO of Expedera.

Advanced Space Demonstrates Artificial Intelligence for Spacecraft Autonomy at the Moon

Retrieved on: 
星期四, 三月 21, 2024
Automation, Artificial neural network, NN, Artificial intelligence, Classification, Microelectronics, Software, Spacecraft, Telemetry, Anomaly, IARPA, Intelligence, Machine learning, Software engineering, Kálmán, Orbit, Communications satellite

WESTMINSTER, Colo., March 21, 2024 /PRNewswire/ -- Today, Advanced Space, LLC, a leading space tech solutions company announced the successful use of machine learning in cislunar space. The Cislunar Autonomous Positioning System Technology Operations and Navigation Experiment (CAPSTONE™) spacecraft has been busy testing new software that is laying the groundwork for a substantial and transformative advance in autonomous navigation in orbit.

Key Points: 
  • WESTMINSTER, Colo., March 21, 2024 /PRNewswire/ -- Today, Advanced Space, LLC , a leading space tech solutions company announced the successful use of machine learning in cislunar space.
  • This is part of a study for the Intelligence Advanced Research Projects Activity (IARPA) under the MicroE4AI (Microelectronics for Artificial Intelligence) program.
  • The capabilities of SigmaZero build upon the Advanced Space mission of developing cutting-edge technologies like machine learning (ML) that improve onboard spacecraft autonomy.
  • We are grateful to our teams of performers, including Advanced Space, who are working diligently to help us meet our program's goals."

CISO GLOBAL RECEIVES VALUATION OF MORE THAN $50 MILLION FOR INITIAL SUITE OF IP SOLUTIONS

Retrieved on: 
星期二, 二月 20, 2024
Cloud, Intel, Algorithm, DISC, AI, Intelligence, Artificial neural network, VPN, Virus, Automation, IP, Machine learning, Artificial intelligence, Medical device

Scottsdale, Ariz., Feb. 20, 2024 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQCM: CISO), an industry leader as a managed cybersecurity and compliance provider, announces the independent valuation of its initial IP Solutions Portfolio by a global leader in valuation, corporate finance, and restructuring. This valuation includes four IP solutions – Skanda7 Breach Assessment Tool, CISO Edge Cloud Security Platform, CHECKLIGHT® Endpoint Security Monitoring, and DISC VPN. The new offerings are representative of the company’s push into delivering software-first solutions.

Key Points: 
  • (NASDAQCM: CISO), an industry leader as a managed cybersecurity and compliance provider, announces the independent valuation of its initial IP Solutions Portfolio by a global leader in valuation, corporate finance, and restructuring.
  • This valuation includes four IP solutions – Skanda7 Breach Assessment Tool, CISO Edge Cloud Security Platform, CHECKLIGHT® Endpoint Security Monitoring, and DISC VPN.
  • CISO Edge Cloud Security Platform – A cloud-first security solution designed to protect users from untrusted and malicious online threats.
  • CISO Global will continue to disrupt the status quo by delivering new IP already in development.”

Andes Technology and Spacetouch Collaborate to Unveil High-Tech Edge-Side AI Audio Processor Featuring the Powerful RISC-V AndesCore™ D25F

Retrieved on: 
星期一, 一月 8, 2024
ECC, Digital, ISA, Artificial neural network, AHB, DSP, SPI, Andes Technology, AI, Human, AXI, Socs, CPU, PLIC, Noise, NPU, ACE, I2S, Acceleration, Algorithm, UART, Video game

Andes Technology's D25F processor, based on the AndeStar™ V5 architecture, is a 32-bit RISC-V CPU IP core equipped with P-extension (DSP/SIMD extension, draft version).

Key Points: 
  • Andes Technology's D25F processor, based on the AndeStar™ V5 architecture, is a 32-bit RISC-V CPU IP core equipped with P-extension (DSP/SIMD extension, draft version).
  • The SPV60 series of on-device AI audio processors integrate the Andes D25F core and Spacetouch’s newly developed uDSP and AI NPU (Neural Network Processor).
  • "The combination of the D25F RISC-V processor and Spacetouch’s heterogeneous multi-core AI audio processor IC brings more innovation and possibilities to the fields of audio processing, embedded systems and mobile devices.
  • "We are very excited that Spacetouch launched this new generation edge-side AI audio processor chips in collaboration with Andes.

VeriSilicon Unveils the New VC9800 IP for Next Generation Data Centers

Retrieved on: 
星期一, 一月 8, 2024
Semiconductor, Hardware, Data Management, Technology, Artificial Intelligence, Dai, Artificial neural network, Consumer Electronics Show, Data center, GM, Recursive neural network, VPU, Data, AI, GPU, IP, Cloud computing, VVC, NPU, CES, Video game

The newly launched series IP caters to the advanced requirements of next generation data centers including video transcoding servers, AI servers, virtual cloud desktops, and cloud gaming.

Key Points: 
  • The newly launched series IP caters to the advanced requirements of next generation data centers including video transcoding servers, AI servers, virtual cloud desktops, and cloud gaming.
  • The VC9800 series of VPU IP boasts high performance, high throughput, and server-level multi-stream encoding and decoding capabilities.
  • Through Rapid Look Ahead encoding, the VC9800 series IP improves video quality significantly with low memory footprint and encoding latency.
  • The VC9800 series of VPU IP can seamlessly interface with Neural Network Processor (NPU) IP, enabling a complete AI-video pipeline.

WaveMaker Marks 2023 with Technology Leadership in AI-infused Low-Code, Recognition by Five Industry Analysts

Retrieved on: 
星期一, 十二月 18, 2023
Universe, Artificial neural network, API, Synthetic media, Wavemakers, Software, Research, AI, Generative, Mount Everest, WaveMaker, Growth, Medical device

In a comprehensive evaluation of 24 prominent vendors, Everest’s research emphasized WaveMaker’s strengths in customizability and API-first approach in low-code application development.

Key Points: 
  • In a comprehensive evaluation of 24 prominent vendors, Everest’s research emphasized WaveMaker’s strengths in customizability and API-first approach in low-code application development.
  • The report commended the platform’s commercial flexibility which makes it an affordable and viable choice for businesses of all sizes.
  • Such a component discovery capability makes WaveMaker teams move dramatically faster as the number of apps in the enterprise grows.
  • As WaveMaker looks back on 2023 with pride, the company eagerly anticipates a year of substantial customer growth and continued success in 2024.

Global AI in Pathology Market Analysis Report 2023-2028: Transforming Diagnostic Decision-Making with Advanced Computational Tools with Drug Discovery Dominating

Retrieved on: 
星期二, 十一月 7, 2023
Hologic, RNN, Artificial neural network, Therapy, Drug discovery, Marie Cassidy, Toxicology, Region, HIV disease progression rates, R, Software, Workflow, Growth, GAN, Diagnosis, Medicine, Hospital, USD, CNN, Algorithm, Component, AI, Investment, Prohibition, Patient, Patient safety, Medical device, Medical imaging, Fine chemical, Health care, Research, Pathology, Biotechnology, Prognosis, Education

This market focuses on harnessing AI algorithms, machine learning methodologies, and advanced computational tools to augment and automate various facets of the pathology workflow.

Key Points: 
  • This market focuses on harnessing AI algorithms, machine learning methodologies, and advanced computational tools to augment and automate various facets of the pathology workflow.
  • Within the AI in pathology market, firms engage in the development, deployment, and utilization of AI technologies meticulously crafted for pathology applications.
  • In 2022, the drug discovery segment held the largest share of the AI in pathology market.
  • These factors contribute to the substantial share of the drug discovery application segment in the AI in pathology market.

AI in Pathology Market Research Report 2023-2028: Focus on Drug Discovery, Diagnosis, Prognosis, Workflow, Education, Pharma, Biotech, Hospital Labs, &m Research - ResearchAndMarkets.com

Retrieved on: 
星期一, 十一月 6, 2023
Technology, Artificial Intelligence, Hologic, RNN, Artificial neural network, Therapy, Drug discovery, Marie Cassidy, Toxicology, Region, HIV disease progression rates, R, Software, Workflow, Growth, GAN, Diagnosis, Medicine, Hospital, USD, CNN, Algorithm, Component, AI, Investment, Prohibition, Patient, Patient safety, Medical device, Medical imaging, Fine chemical, Health care, Research, Pathology, Biotechnology, Prognosis, Education

This market focuses on harnessing AI algorithms, machine learning methodologies, and advanced computational tools to augment and automate various facets of the pathology workflow.

Key Points: 
  • This market focuses on harnessing AI algorithms, machine learning methodologies, and advanced computational tools to augment and automate various facets of the pathology workflow.
  • Within the AI in pathology market, firms engage in the development, deployment, and utilization of AI technologies meticulously crafted for pathology applications.
  • In 2022, the drug discovery segment held the largest share of the AI in pathology market.
  • These factors contribute to the substantial share of the drug discovery application segment in the AI in pathology market.